Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Classifica tra le azioni #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Prezzo delle azioni
$0.05124204
Capitalizzazione di mercato
$7.78M
Variazione (1 giorno)
0.51%
Variazione (1 anno)
-23.73%
Paese
CH
Scambia Addex Therapeutics Ltd (ADXN)

Categoria

Cronologia dei frazionamenti azionari per Addex Therapeutics Ltd (ADXN)
L’azione Addex Therapeutics Ltd (simbolo: ADXN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 17, 2026.
Una quota di ADXN acquistata prima di Aug 17, 2026 equivale oggi a 0 quote di ADXN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE